SCHEMBL7988249

SCHEMBL7988249

CCCCn1cnc2nc(-c3ccccc3)[nH]c(=O)c21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.50
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ADORA2A P29274 3/20 0.48
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
ADORA2B P29275 3/20 0.47
XDH P47989 1/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
HPGD P15428 3/20 0.44
NPC1 O15118 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985373 0.96 PDE5A (0.49) PDE5AALDH1A1MEN1KMT2AADORA2A
SCHEMBL7974064 0.95 XDH (0.48) PDE5AALDH1A1MEN1KMT2AADORA2A
SCHEMBL7984998 0.93 PDE5A (0.52) PDE5AALDH1A1MEN1KMT2AADORA2A
SCHEMBL7988488 0.87 BRD4 (0.50) PDE5AALDH1A1MEN1KMT2AADORA2A
SCHEMBL7984240 0.87 LMNA (0.58) PDE5AALDH1A1MEN1KMT2AKDM4E
SCHEMBL7974613 0.84 CNOT7 (0.49) PDE5AALDH1A1KMT2AKDM4ELMNA
SCHEMBL7985282 0.83 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AADORA2APDE4A
SCHEMBL7984495 0.81 HPGD (0.47) PDE5AALDH1A1MEN1KMT2AADORA2A
SCHEMBL7985781 0.81 MEN1 (0.46) ALDH1A1MEN1KMT2AADORA2APDE4A
SCHEMBL7975265 0.81 SMN1; SMN2 (0.61) ALDH1A1MEN1KMT2AADORA2BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed